-+ 0.00%
-+ 0.00%
-+ 0.00%

CUMBERLAND PHARMACEUTICALS - TO SUBMIT NDA TO FDA FOR IFETROBAN AS DMD CARDIOMYOPATHY TREATMENT

Reuters·10/26/2026 20:40:00

Please log in to view news